Thrivent Financial for Lutherans
TVTX icon

Thrivent Financial for Lutherans’s Travere Therapeutics TVTX Stock Holding History

Thrivent Financial for Lutherans’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$702K Buy
+12,350
New +$548K ﹤0.01% 2160
2026
Q1 		– Sell
-8,986
Closed -$343K – 2664
2025
Q4 		$343K Buy
+8,986
New +$292K ﹤0.01% 2373
2023
Q3 		– Sell
-171,115
Closed -$2.63M – 2499
2023
Q2 		$2.63M Sell
171,115
-92,384
-35% -$1.68M 0.01% 1172
2023
Q1 		$5.93M Buy
263,499
+95,562
+57% +$2.03M 0.01% 756
2022
Q4 		$3.53M Buy
167,937
+2,403
+1% +$50.9K 0.01% 926
2022
Q3 		$4.08M Buy
165,534
+9,960
+6% +$257K 0.01% 858
2022
Q2 		$3.77M Sell
155,574
-27,679
-15% -$696K 0.01% 916
2022
Q1 		$4.72M Sell
183,253
-187
-0.1% -$4.96K 0.01% 912
2021
Q4 		$5.69M Sell
183,440
-79,352
-30% -$2.23M 0.01% 848
2021
Q3 		$6.37M Buy
+262,792
New +$4.83M 0.01% 813
2021
Q2 		– Sell
-247,011
Closed -$6.17M – 2525
2021
Q1 		$6.17M Buy
247,011
+82,628
+50% +$2.28M 0.01% 837
2020
Q4 		$4.48M Buy
164,383
+105,861
+181% +$2.47M 0.01% 904
2020
Q3 		$1.08M Buy
+58,522
New +$1.14M ﹤0.01% 1527

Other funds holding TVTX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Thrivent Financial for Lutherans's TVTX Position: Q2 2026 in Review

Thrivent Financial for Lutherans opened a new position in Travere Therapeutics (TVTX) in Q2 2026: 12,350 shares worth $702K. The stake represents ﹤0.01% of the portfolio and ranks #2160 among its holdings. This is a return to the name: Thrivent Financial for Lutherans previously reported a position in TVTX as recently as Q4 2025.

Thrivent Financial for Lutherans first reported a position in TVTX in Q3 2020 and has held it in 13 quarters since. The position peaked at $6.37M in Q3 2021. 321 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Thrivent Financial for Lutherans held 12,350 shares of Travere Therapeutics worth $702K as of Q2 2026.
  • Travere Therapeutics was a new Thrivent Financial for Lutherans position in Q2 2026.
  • Travere Therapeutics made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #2160 holding.
  • Thrivent Financial for Lutherans first reported a position in Travere Therapeutics in Q3 2020 and has held it in 13 quarters since.
  • Thrivent Financial for Lutherans's Travere Therapeutics position peaked at $6.37M in Q3 2021.
  • 321 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.